Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection

FEMS Immunology and Medical Microbiology

Volumn 27, Issue 4, 2000, Pages 291-297

  Gilleland Jr , Harry E ^a   Gilleland, Linda B ^a   Staczek, John ^a   Harty, Ronald N ^b   García Sastre, Adolfo ^c   Palese, Peter ^c   Brennan, Frank R ^d   Hamilton, William D O ^d   Bendahmane, Mohammed ^e   Beachy, Roger N ^e  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Axis Genetics plc   (United Kingdom)

^e DONALD DANFORTH PLANT SCIENCE CENTER   (United States)

Author keywords

Chimeric virus vaccine; Cowpea mosaic virus; Epitope vaccine; Influenza virus; Outer membrane protein F; Pseudomonas aeruginosa; Tobacco mosaic virus

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE PROTEIN; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; BACTERIAL OUTER MEMBRANE; CHIMERA; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLUENZA VIRUS; LUNG INFECTION; MOSAIC VIRUS; MOUSE; NONHUMAN; PLANT VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; TOBACCO MOSAIC VIRUS; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; COMOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; INFLUENZA A VIRUS; LUNG; LUNG DISEASES; MICE; PLANT VIRUSES; PORINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RECOMBINANT FUSION PROTEINS; TOBACCO MOSAIC VIRUS; VACCINATION; VACCINES, COMBINED; VACCINES, SYNTHETIC;

EID: 0342948671     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00206-0     Document Type: Article

References (25)

1. Eagon, R.G., Stinnett, J.D. and Gilleland, H.E., Jr. (1975) Ultrastructure of Pseudomonas aeruginosa as related to resistance. In: Resistance of Pseudomonas aeruginosa (Brown, M.R.W., Ed.), pp. 109-143. John Wiley and Sons, London.
2. Matthews-Greer J.M., Robertson D.E., Gilleland L.B., Gilleland H.E. Jr. Pseudomonas aeruginosa outer membrane protein F produced in Escherichia coli retains vaccine efficacy. Curr. Microbiol. 20:1990;171-175.
3. Gilleland H.E. Jr., Parker M.G., Matthews J.M., Berg R.D. Use of purified outer membrane protein F (porin) of Pseudomonas aeruginosa as a protective vaccine in mice. Infect. Immun. 44:1984;49-54.
4. Matthews-Greer J.M., Gilleland H.E. Jr. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model. J. Infect. Dis. 155:1987;1282-1291.
5. Gilleland H.E. Jr., Gilleland L.B., Matthews-Greer J.M. Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in rats. Infect. Immun. 56:1988;1017-1022.
6. Gilleland H.E. Jr., Gilleland L.B., Hughes E.E., Matthews-Greer J.M. Recombinant outer membrane protein F of Pseudomonas aeruginosa elicits antibodies that mediate opsonophagocytic killing, but not complement-mediated bacteriolysis, of various strains of P. aeruginosa. Curr. Microbiol. 24:1992;1-7.
7. Mutharia L.M., Nicas T.I., Hancock R.E.W. Outer membrane proteins of Pseudononas aeruginosa serotype strains. J. Infect. Dis. 146:1982;770-779.
8. Counts G.W., Schwartz R.W., Ulness B.K., Hamilton D.J., Rosok M.J., Cunningham M.D., Tam M.R., Darveau R.P. Evaluation of an immunofluorescent-antibody test for rapid identification of Pseudomonas aeruginosa in blood cultures. J. Clin. Microbiol. 26:1988;1161-1165.
9. Gilleland L.B., Gilleland H.E. Jr. Synthetic peptides representing two protective, linear B cell epitopes of outer membrane protein F of Pseudomonas aeruginosa elicit whole-cell-reactive antibodies that are functionally pseudomonad specific. Infect. Immun. 63:1995;2347-2351.
10. 125I]lactoperoxidase. FEMS Microbiol. Lett. 14:1982;43-45.
11. Mutharia L.M., Hancock R.E.W. Surface localization of Pseudomonas aeruginosa outer membrane porin protein F by using monoclonal antibodies. Infect. Immun. 42:1983;1027-1033.
12. Gilleland H.E. Jr., Hughes E.E., Gilleland L.B., Matthews-Greer J.M., Staczek J. Use of synthetic peptides to identify surface-exposed, linear B-cell epitopes within outer membrane protein F of Pseudomonas aeruginosa. Curr. Microbiol. 31:1995;279-286.
13. Gotoh N., Wakebe H., Yoshihara E., Nakae T., Nishino T. Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane. J. Bacteriol. 171:1989;983-990.
14. Hughes E.E., Gilleland L.B., Gilleland H.E. Jr. Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa. Infect. Immun. 60:1992;3497-3503.
15. Hughes E.E., Gilleland H.E. Jr. Ability of synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa to afford protection against P. aeruginosa infection in a murine acute pneumonia model. Vaccine. 13:1995;1750-1753.
16. Gilleland H.E. Jr., Gilleland L.B., Staczek J., Harty R.N., Garcia-Sastre A., Engelhardt O.G., Palese P. Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa. Behring Inst. Mitt. 98:1997;291-301.
17. Staczek J., Gilleland H.E. Jr., Gilleland L.B., Harty R.N., Garcia-Sastre A., Enelhardt O.G., Palese P. A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection. Infect. Immun. 66:1998;3990-3994.
18. Brennan F.R., Jones T.D., Gilleland L.B., Bellaby T., Xu F., North P.C., Thompson A., Staczek J., Lin T., Johnson J.E., Hamilton W.D.O., Gilleland H.E. Jr. Pseudomonas aeruginosa outer membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus. Microbiology. 145:1999;211-220.
19. Brennan F.R., Gilleland L.B., Staczek J., Bendig M.M., Hamilton W.D.O., Gilleland H.E. Jr. A chimeric plant virus vaccine protects mice against a bacterial infection. Microbiology. 145:1999;2061-2067.
20. Fitchen J.H., Beachy R.N., Hein M.B. Plant virus expressing hybrid coat protein with added murine epitope elicits autoantibody response. Vaccine. 13:1995;1051-1057.
21. Beachy R.N., Fitchen J.H., Hein M.B. Use of plant viruses for delivery of vaccine epitopes. Ann. N.Y. Acad. Sci. 792:1996;43-49.
22. Koo M., Bendahmane M., Lettieri G.A., Paoletti A.D., Lane T.E., Fitchen J.H., Buchmeier M.J., Beachy R.N. Protective immunity against murine hepatitis virus induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proc. Natl. Acad. Sci. USA. 96:1999;7774-7779.
23. Bendahmane M., Koo M., Karrer E., Beachy R.N. Display of epitopes on the surface of tobacco mosaic virus: impact of charge and isoelectric point of the epitope on virus-host interactions. J. Mol. Biol. 290:1999;9-20.
24. Boudet F., Theze J., Zouali M. UV-treated polystyrene microtiter plates for use in an ELISA to measure antibodies against synthetic peptides. J. Immunol. Methods. 142:1991;73-82.
25. Starke J.R., Edwards M.S., Langston C., Baker C.J. A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr. Res. 22:1987;698-702.